Leveraging the Potential of Induction Therapy in Human Papillomavirus-Mediated Oropharyngeal Carcinoma

Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):179-181. doi: 10.1016/j.ijrobp.2023.09.035.

Authors

Ezra Hahn¹, Shao Hui Huang²

Affiliations

¹ Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada. Electronic address: ezra.hahn@uhn.ca.
² Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada; Department of Otolaryngology - Head & Neck Surgery, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.

PMID: 38049223
DOI: 10.1016/j.ijrobp.2023.09.035

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Squamous Cell* / pathology
Human Papillomavirus Viruses
Humans
Induction Chemotherapy
Oropharyngeal Neoplasms* / pathology
Oropharyngeal Neoplasms* / radiotherapy
Papillomaviridae
Papillomavirus Infections* / complications